Skip to main content
. 2011 Feb 14;17(6):809–816. doi: 10.3748/wjg.v17.i6.809

Table 4.

Correlation between K-ras mutations and clinicopathological factors in colorectal cancer n (%)

Terms All Wild type Mutation type P value
No. of patients 118 77 (65.3) 41 (34.7)
Gender 0.037
Male 71 51 (71.8) 20 (28.2)
Female 47 26 (55.3) 21 (44.7)
Median age (yr) 61.0 64.0 60.0 0.728
Males 65.0 65.0 65.5
Females 60.0 60.5 58.0
Colorectal segment 0.559
Cecum 5 1 (20.0) 4 (80.0)
Ascending colon 23 17 (73.9) 6 (26.1)
Transversal colon 8 4 (50.0) 4 (50.0)
Descending colon 5 4 (80.0) 1 (20.0)
Sigmoid 25 16 (64.0) 9 (36.0)
Rectum 52 35 (67.3) 17 (32.7)
Differentiation 0.761
Poor 17 12 (70.6) 5 (29.4)
Moderate 42 25 (59.5) 17 (40.5)
Well 59 40 (67.8) 19 (32.2)
UICC classification 0.631
I 18 9 (50.0) 9 (50.0)
II 48 37 (77.1) 11 (22.9)
III 37 23 (62.2) 14 (37.8)
IV 15 8 (53.3) 7 (46.7)
Bowel wall invasion (pT) 0.120
pT1 2 1 (50.0) 1 (50.0)
pT2 21 11 (52.4) 10 (47.6)
pT3 65 43 (66.2) 22 (33.8)
pT4 30 22 (73.3) 8 (26.7)
Lymph node metastasis (pN) 0.585
pN0 69 47 (68.1) 22 (31.9)
pN1-2 49 31 (63.3) 18 (36.7)
Distant metastasis (pM) 0.301
pM0 103 70 (68.0) 33 (32.0)
pM1 15 8 (53.3) 7 (46.7)

UICC: Union for International Cancer Control.